Home › Lupus › Georgia › Atlanta
Lupus clinical trials in Atlanta, GA
7 studies for Lupus are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
RecruitingPhase 3
- Emory University School of Medicine, Atlanta
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
RecruitingPhase 3
- Morehouse School of Medicine, Atlanta
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
RecruitingObservational study
- Local Institution - 0069, Atlanta
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
RecruitingPhase 1/2
- Emory University, Atlanta
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
RecruitingPhase 1/2
- Research Site, Atlanta
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
RecruitingPhase 3
- Emory University School of Medicine, Atlanta
Lupus Landmark Study: A Prospective Registry and Biorepository
RecruitingObservational study
- Emory University, Atlanta
About Lupus
Lupus is an autoimmune disease that causes your immune system to attack your healthy tissues and cells. This can cause damage to many parts of your body.
More about Lupus on MedlinePlus
Lupus trials in other cities
- New York City, NY18 studies
- Houston, TX14 studies
- Durham, NC12 studies
- Washington, DC11 studies
- Miami, FL10 studies
- Oklahoma City, OK9 studies
- San Diego, CA8 studies
- Tampa, FL8 studies
- Boston, MA8 studies
- Chicago, IL8 studies
- Philadelphia, PA8 studies
- Santa Monica, CA7 studies
Other studies in Atlanta
- Cancer (all types)49 studies
- Non-Small Cell Lung Cancer48 studies
- Multiple Myeloma42 studies
- Breast Cancer42 studies
- Prostate Cancer36 studies
- Acute Myeloid Leukemia30 studies
- Metastatic Cancer29 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Lung Cancer28 studies
- Obesity26 studies
- Major Depressive Disorder24 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.